WADA – World Anti-Doping Agency
Montreal, 1 May 2019
Annually, there is an agreed process for reviewing content and structural changes to the List of Prohibited Substances and Methods (Prohibited List), which is an International Standard under Article 4.1 of the World Anti-Doping Code (Code).
As part of this process, stakeholder feedback is collected throughout the year; and then, in April of every year, WADA’s List Expert Group meets to discuss the feedback, evidence and proposed content and/or structural changes, and to formulate the draft Prohibited List.
On 11 and 12 April, the List Expert Group held a meeting that resulted in the following documents, which we are confidentially giving you access to today for Stakeholder Consultation, via WADAConnect, the Agency’s online stakeholder consultation platform:
Draft 2020 Prohibited List
Summary of Modifications, which is intended to facilitate your review
2020 Monitoring Program
As is customary, WADA kindly asks that someone within your organization, with the relevant professional experience and expertise in anti-doping, be given the opportunity to carefully review the draft 2020 Prohibited List and provide comments concerning the proposed content (additions, subtractions or other modifications) and/or structural changes. We would ask that, whenever possible, your comments be supported by relevant reference(s) to medical or scientific evidence; pharmacological effect; and/or, personal experience concerning the substances or methods in question.
Also, as was done last year, the WADAConnect platform will encourage you, separately, to propose further additions, subtractions or other modifications under ‘Comments for future consideration’; which will be evaluated and considered carefully over the course of the year but will not likely be incorporated within the 2020 Prohibited List.
To provide comments
Simply connect to WADAConnect. If you do not currently have access, please consult the short guide on how to create a user account that is available on the platform.
Once you have a user account, please inform email@example.com and ask to be added to the private List Consultation Group. This is necessary in order to provide comments.
Please input your comments by 12 July 2019.
We believe that conducting this Stakeholder Consultation helps ensure that the Prohibited List evolves in step with the highest possible scientific standards; and, reflects the needs of the anti-doping community.
In keeping with the annual process, the 2020 Prohibited List will not be made public until 1 October 2019. Therefore, we would ask you to ensure that the draft is kept confidential in order to preserve the integrity of the Stakeholder Consultation process. As we know, earlier publication would compromise the process and lead to confusion in the minds of athletes and other stakeholders worldwide.
Should you have any questions or concerns, please contact firstname.lastname@example.org.
Thank you in advance for your organization’s feedback.
World Anti-Doping Agency
The World Anti-Doping Agency (WADA) is pleased to announce the appointment of Amanda Hudson as WADA’s new Director of Education, effective 5 August 2019.
Ms. Hudson, who is currently Head of Education for UK Anti-Doping in London, will lead the development and implementation of WADA’s education strategy, programs and activities, including managing WADA’s Social Science Research Grant Program and the Agency’s Education Committee.
In October 2018, Director of Communications, Catherine MacLean, assumed leadership of the education portfolio and set out to recruit a Deputy Director of Education to help develop and drive WADA’s education strategy. Due to the quality of the applications received during the recruitment phase, management decided to upgrade the role to Director, carving education out as a stand-alone department with a seat at the management table. This optimized structure reflects the increasing importance with which WADA and its stakeholders view the areas of both education and communications to the Agency and the global anti-doping program.
WADA Director General Olivier Niggli said: “I am delighted that Amanda will be joining WADA to take on this important mandate as the Director of Education. With almost 15 years connected to sport, nine of which with UKAD, Amanda brings with her a wealth of experience in developing and delivering excellent anti-doping education programs. Her strategic approach and leadership are exactly what we need to bring this core business activity to the next level.
“WADA’s success depends on its 100+ team of committed and skilled individuals. This appointment will reinforce WADA’s Management Team and will help the Agency deliver on its mission for athletes and other stakeholders in 2019 and beyond.”
Amanda Hudson will be located at WADA’s head office in Montreal, Canada. Until Ms. Hudson’s arrival in August, Ms. MacLean will maintain leadership of Education in addition to Communications.
Montreal, 30 April 2019 – Since January’s retrieval by the World Anti-Doping Agency (WADA) of the analytical data generated by the former Moscow Laboratory in Russia, WADA Intelligence and Investigations (I&I) has been working on a mission to extract all relevant samples still contained within the laboratory.
WADA can confirm that a five-person team has successfully retrieved 2,262 samples from the laboratory, which had been split into A and B samples and contained within 4,524 collection bottles. The samples have now been taken out of Moscow and are on their way to a WADA-accredited laboratory outside of Russia. Importantly, all samples targeted by I&I in advance of the mission were successfully located and extracted.
WADA Director of I&I Gunter Younger, who is leading the process, said: “WADA Intelligence and Investigations is pleased to be continuing to make progress in this complex and difficult case. Extracting the required samples from the laboratory is another step forward. These samples will be used to strengthen cases against those who may have cheated and may exonerate athletes who have not committed an anti-doping rule violation.”
“In removing the bottles, as a precaution we decided to take any and all samples that corresponded to data in the Laboratory Information Management System (LIMS) database that was even remotely anomalous, even where an anti-doping rule violation (ADRV) was not suspected. We can therefore proceed to the next phase and support the various International Federations (IFs) and other Anti-Doping Organizations to bring cases forward.”
In parallel, the authentication process of the Moscow data is close to completion. In early May, a progress report from that process will be sent to the independent Compliance Review Committee – which has received updates from WADA I&I every two weeks since the data was extracted in January – and an update will be presented at the next meetings of WADA’s Executive Committee and Foundation Board on 15 and 16 May, respectively.
Meanwhile, the process continues as I&I investigators identify all available evidence for each case, including ordering further sample analysis, where appropriate. In due course, the relevant IFs will be presented with evidentiary packages, which they will assess with the view to taking the cases forward as ADRVs. In cases where IFs choose not to take action, WADA will review the facts, discuss with the relevant IF and reserves the right to bring them forward to the Court of Arbitration for Sport.
Last week, WADA held a conference call with a number of IFs outlining the next steps and answering any questions they might have. Similar conference calls have also been held with athletes and with National Anti-Doping Organizations (NADOs).
Background: The successful data and sample retrieval came about as a result of the 20 September 2018 decision of WADA’s Executive Committee to reinstate the Russian Anti-Doping Agency (RUSADA), under strict conditions, to the list of World Anti-Doping Code-compliant Signatories. Under the terms of that decision, the Russian authorities were required to provide the data while also agreeing that any samples required by WADA for re-analysis would be made available by 30 June 2019. The samples had been stored and sealed off as part of a federal investigation being carried out by Russian authorities.
Further information: WADA has produced a flowchart that summarizes the three phases of the RUSADA Compliance Process and has compiled a document that summarizes the ‘Progress of the Anti-Doping System in Light of the Russian Doping Crisis’.
Montreal, 29 April 2019
The World Anti-Doping Agency (WADA) is pleased to launch a series of Therapeutic Use Exemption (TUE) Checklists to provide guidance and support to athletes, their physicians and Anti-Doping Organizations (ADOs) during the TUE application process.
These new Checklists are based on the TUE Committee Guidelines (TUEC Guidelines) (Medical Information to Support the Decisions of TUECs documents); which were developed by WADA and external medical specialists primarily for TUECs. The Checklists – which cover the most commonly seen conditions – list the requirements for completing the TUE Application Form, including the medical evidence that must be submitted along with it.
Following a successful pilot project with a number of National Anti-Doping Organizations and International Federations over the last few months, we now invite all ADOs to use the Checklists in their interactions with athletes and applying physicians. We also invite stakeholders to adapt the official English versions by translating and customizing them as necessary – while ensuring that the key elements remain.
ADOs interested in making their translations available on WADA’s website are strongly encouraged to do so and to send their translations to email@example.com by 17 May 2019. We will be posting all TUE checklists on the WADA website after this date.
We thank you in advance for your efforts and collaboration in adopting these Checklists. Should you have any questions or wish to provide feedback, please contact firstname.lastname@example.org.
Montreal, 24 April 2019 – A newly developed method for detecting the use of prohibited substances in athletes has led to a significant and unprecedented 29 March 2019 decision by the Court of Arbitration for Sport (CAS) in favour of the World Anti-Doping Agency (WADA).
CAS issued a final award confirming Anti-Doping Rule Violations (ADRVs) in the cases of the Ukrainian track and field athletes, Olesia Povh and Olha Zemliak. Both athletes were convicted of using a prohibited substance based on the detection of non-physiological levels of testosterone in their blood serum samples following analysis in the WADA-accredited laboratories in Lausanne, Switzerland, and Seibersdorf, Austria.
The testing was initiated by the Athletics Integrity Unit (AIU) of the International Association of Athletics Federations (IAAF). This led to the subsequent investigation, which resulted in these important convictions. The measurement of testosterone levels in blood serum constitutes a further tool for Anti-Doping Organizations (ADOs) to detect and prosecute doping, even where urine samples might be reported as negative.
WADA Director General Olivier Niggli said: “WADA welcomes this decision by CAS, which could have a long-term positive impact on clean sport. I would also like to commend the AIU for their excellent work which led to this outcome. The decision sets an important precedent and this new method of detecting doping represents another way for ADOs to secure Anti-Doping Rule Violations against those who choose to cheat. It is a significant victory for clean sport and for athletes around the world.”
Significantly, CAS ruled that there could be no doubt on the evidence that the method used in measuring testosterone in blood serum was scientifically valid, paving the way for further examples of this method being used in the future.
Olesia Povh was sanctioned with a four-year period of ineligibility for intentional doping while Olha Zemliak received an eight-year period of ineligibility as it was her second violation.
Athens, 5 April 2019 – Yesterday, the World Anti-Doping Agency’s (WADA’s) Director General, Olivier Niggli, addressed a two-day conference in Athens, Greece, being held to commemorate the 30th anniversary of the Council of Europe’s Anti-Doping Convention (Convention).
This year marks three decades since the Convention was open for signature – a treaty that has now been ratified by all 47 Council of Europe member countries and several other states. Arriving 10 years before WADA was formed, the Convention helped to prepare the way for the Agency’s work by standardizing and harmonizing measures to tackle doping across all boundaries.
Olivier Niggli told the conference that while the success of the Convention and many other measures in protecting clean sport were clear, now was not the time for complacency.
“Without a doubt there is much more work to be done and improvements to be made,” he said. “The fight against doping is not static. It evolves every day and none of us should rest on our laurels. Together, the Council of Europe, Member States, WADA, UNESCO, the Sport Movement and all other players within the anti-doping community must go further by improving our methods, our rules, our science, our monitoring, our education programs, our investigative capabilities and much more.
“The input of governments, such as those represented at this important conference, is paramount to going further and making a difference. We need them as a crucial part of the team. The athletes make all of us proud every day through their hard efforts, their excellence and their dedication. They act as role models for the youth and make their nations’ flags fly on the world stage. We owe them our full commitment – to protect them and the sports they love.
“Over the years, WADA has been working very closely with the Council of Europe on a range of issues, including matters related to monitoring the compliance of anti-doping programs. This partnership has allowed for a crossover of important expertise, which benefits both organizations in increasing their respective efficiency while avoiding duplication of resources.
“On behalf of WADA, I wish to thank Europe for their commitment, their investment and their relentless efforts in protecting clean sport and society.”
An introduction and overview on Anti-Doping.
What is Doping
According to the CPISRA Anti Doping Rules compliant to WADA Code, Doping is defined as:
- Presence of a prohibited Substance or its metabolites or markets , as defined in the WADA Prohibited List in an athlete’s bodily specimen, except when in agreement with a TUE granted for the particular substance.
- Use or attempted use of a Prohibited Substance or Methods.
- Tampering or attempting to temper with any part of Doping Control.
- Violation of applicable requirements regarding Athlete availability for Out-of-Competition Testing for RTP (Registered Testing Pool) athletes.
- Possession or trafficking of Prohibited Substances and Methods.
- Administration or attempted administration of a Prohibited Substance or Method to any athlete , or assisting ,encouraging ,aiding , abetting , covering up or any other type of complicity involving an anti-doping rule.
- Administration or Attempted Administration to any Athlete In-Competition of any Prohibited Substance or Prohibited Method, or Administration or Attempted Administration to any Athlete Out-of-Competition of any Prohibited Substance or any Prohibited Method that is Prohibited Out-of-Competition
–Complicity : Assisting, encouraging, aiding, abetting, conspiring, covering up or any other type of intentional complicity involving an anti-doping rule violation.
–Prohibited Association : Association by an Athlete or other Person subject to the authority of an Anti-Doping Organization in a professional or sport-related capacity with any ineligible Athlete / Support Person because of an Anti-Doping rule Violation or equivalent case.
Why is Doping Prohibited
The sports regulations prohibit Doping. Any violation of this rules, be it voluntary or not, constitutes a failure to respect the principle of equal opportunities and, therefore, a disrespect of the sports ethics.
Moreover, the consumption of substances which improve performances can put health in danger. The athlete who has resort to Doping doesn’t harm only himself but he also negatively affects sports as a whole.
What are the tasks of the CPISRA Anti-Doping Committee
In 2005, CPISRA constituted a Committee for the fight against Doping charged of the execution of controls and the surveillance of the tests. This committee is responsible for education of CP athletes concerning anti doping, for the conception and the respect of the anti doping rules, for the diffusion of the Prohibited list , for the formation and perfection of the controllers and also the provision information and advice. Its activities are defined through the Anti Doping Committee Statue.
What about medicines provided on order?
The athlete who must follow a treatment should draw the attention of his/her physician and/or pharmacist to the list of the relevant Doping substances.
If he/she obtains medicines from abroad, he/she must take care of their composition which is mentioned on the note devoted to the patients. The ideal would be to carry away his/her own medicines.
Each athlete should establish, with the help of his/her physician or pharmacist, a personal list of the medicines that he can consume in case of illness- personal medication notebook, this would prevent him from absorbing prohibited substances involuntarily.
The Therapeutic Use Exemption (TUE)
A TUE may be granted to an Athlete permitting the use of Prohibited Substance or Prohibited Methods as defined by the Prohibited List for the following reasons:
-The Athlete would experience a significant impairment to health if the Prohibited Substance or Prohibited Method would produce no additional enhancement of performance other than that which might be anticipated by a return to a state of usual health following the treatment of a legitimate medical condition.
-There is no reasonable therapeutic alternative to the Use of the otherwise Prohibited Substance or Prohibited Method.
-The necessity for the Use of the otherwise Prohibited Substance or Prohibited Method cannot be a consequence , wholly or in part , of the prior non –therapeutic Use of substances from the Prohibited List.
How long do the medicines remain detectable in urine?
What is an anti-doping control?
An anti-doping control consists in analyzing, by accredited laboratories, the urine or blood withdrawals of selected athletes in order to track down the prohibited substances. The discovery of such substances results in tacking disciplinary measures against the athlete. Anti-doping control assures the respect of equal opportunities in competition.
Who is submitted to the controls
Who is responsible for anti-doping controls?
Who is in charge of controls?
During the controls, what about disabled athletes?
What does it occur to urine (or blood) withdrawals?
Are the sample of urine (or blood) safe from manipulation?
Are the tests unfailing?
What happens when the result of controls it is negative?
What happens when the result of controls is positive?
The results of Out of competition testing are announced directly by the CPISRA Anti Doping Committee to the athlete.
The athlete can ask in writing for an analysis of the sample B. He has the right to attend this analysis accompanied by an expert and /or a trustworthy person. If the result is negative, the control is declared negative. On the other hand, if the result confirms the one gotten from sample A, the control is declared positive.
The possible sanctions are decided according the CPISRA anti doping rules and applied by the federation of the relevant athlete. Before, the athlete has the right to express himself and to have knowledge of the file. The case must remain confidential until the first instance decision.
It is possible to protest a first instance decision. The protest can be forwarded to an unbiased arbitration court, like WADA and Sport Arbitrary Tribunal in Lausanne.